{"id":"https://openalex.org/W2226252183","doi":"https://doi.org/10.1186/2051-1426-3-s2-p186","title":"Correlation between immune-related adverse events and response to pembrolizumab in advanced melanoma patients","display_name":"Correlation between immune-related adverse events and response to pembrolizumab in advanced melanoma patients","alternate_titles":[],"publication_year":2015,"publication_date":"2015-01-01","ids":{"openalex":"https://openalex.org/W2226252183","doi":"https://doi.org/10.1186/2051-1426-3-s2-p186","mag":"2226252183","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4649387"},"language":"en","primary_location":{"id":"doi:10.1186/2051-1426-3-s2-p186","doi":"https://doi.org/10.1186/2051-1426-3-s2-p186","is_oa":true,"landing_page_url":"https://doi.org/10.1186/2051-1426-3-s2-p186","pdf_url":"https://jitc.biomedcentral.com/track/pdf/10.1186/2051-1426-3-S2-P186","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for ImmunoTherapy of Cancer","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2226252183"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.biomedcentral.com/track/pdf/10.1186/2051-1426-3-S2-P186","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040419545","display_name":"Antonio Maria Grimaldi","orcid":"https://orcid.org/0000-0002-0126-1267","observed_orcids":["https://orcid.org/0000-0002-0126-1267"]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Antonio Grimaldi","raw_affiliation_strings":["Cancer Immunotherapy and Innovative Therapies Istituto Nazionale Tumori di Napoli Fondazione \u201cG. Pascale\u201d","O.U. Melanoma"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Immunotherapy and Innovative Therapies Istituto Nazionale Tumori di Napoli Fondazione \u201cG. Pascale\u201d","institution_ids":["https://openalex.org/I4210141868"]},{"raw_affiliation_string":"O.U. Melanoma","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086592438","display_name":"Ester Simeone","orcid":"https://orcid.org/0000-0003-2964-0434","observed_orcids":["https://orcid.org/0000-0003-2964-0434"]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ester Simeone","raw_affiliation_strings":["Cancer Immunotherapy and Innovative Therapies Istituto Nazionale Tumori di Napoli Fondazione","O.U. Melanoma"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Immunotherapy and Innovative Therapies Istituto Nazionale Tumori di Napoli Fondazione","institution_ids":["https://openalex.org/I4210141868"]},{"raw_affiliation_string":"O.U. Melanoma","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048209523","display_name":"Lucia Festino","orcid":"https://orcid.org/0000-0002-3035-266X","observed_orcids":["https://orcid.org/0000-0002-3035-266X"]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lucia Festino","raw_affiliation_strings":["Cancer Immunotherapy and Innovative Therapies Istituto Nazionale Tumori di Napoli Fondazione","O.U. Melanoma"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Immunotherapy and Innovative Therapies Istituto Nazionale Tumori di Napoli Fondazione","institution_ids":["https://openalex.org/I4210141868"]},{"raw_affiliation_string":"O.U. Melanoma","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086743021","display_name":"Diana Giannarelli","orcid":"https://orcid.org/0000-0002-6085-1195","observed_orcids":["https://orcid.org/0000-0002-6085-1195"]},"institutions":[{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Diana Giannarelli","raw_affiliation_strings":["Regina Elena National Cancer Institute, Rome"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regina Elena National Cancer Institute, Rome","institution_ids":["https://openalex.org/I4387152244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050761946","display_name":"Marco Palla","orcid":"https://orcid.org/0000-0001-8901-0974","observed_orcids":["https://orcid.org/0000-0001-8901-0974"]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marco Palla","raw_affiliation_strings":["Cancer Immunotherapy and Innovative Therapies Istituto Nazionale Tumori di Napoli Fondazione \u201cG. Pascale\u201d","O.U. Melanoma"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Immunotherapy and Innovative Therapies Istituto Nazionale Tumori di Napoli Fondazione \u201cG. Pascale\u201d","institution_ids":["https://openalex.org/I4210141868"]},{"raw_affiliation_string":"O.U. Melanoma","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011521807","display_name":"Corrado Carac\u00f2","orcid":"https://orcid.org/0000-0002-7828-079X","observed_orcids":["https://orcid.org/0000-0002-7828-079X"]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Corrado Carac\u00f2","raw_affiliation_strings":["O.U. Melanoma and Sarcoma Surgery Istituto Nazionale Tumori di Napoli Fondazione \u201cG. Pascale\u201d"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"O.U. Melanoma and Sarcoma Surgery Istituto Nazionale Tumori di Napoli Fondazione \u201cG. Pascale\u201d","institution_ids":["https://openalex.org/I4210141868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072335274","display_name":"Marcello Curvietto","orcid":"https://orcid.org/0000-0003-0734-1863","observed_orcids":["https://orcid.org/0000-0003-0734-1863"]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marcello Curvietto","raw_affiliation_strings":["Cancer Immunotherapy and Innovative Therapies Istituto Nazionale Tumori di Napoli Fondazione","O.U. Melanoma"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Immunotherapy and Innovative Therapies Istituto Nazionale Tumori di Napoli Fondazione","institution_ids":["https://openalex.org/I4210141868"]},{"raw_affiliation_string":"O.U. Melanoma","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074642384","display_name":"Assunta Esposito","orcid":"https://orcid.org/0000-0001-9206-8325","observed_orcids":["https://orcid.org/0000-0001-9206-8325"]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Assunta Esposito","raw_affiliation_strings":["Cancer Immunotherapy and Innovative Therapies Istituto Nazionale Tumori di Napoli Fondazione","O.U. Melanoma"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Immunotherapy and Innovative Therapies Istituto Nazionale Tumori di Napoli Fondazione","institution_ids":["https://openalex.org/I4210141868"]},{"raw_affiliation_string":"O.U. Melanoma","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Maria Grimaldi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I103320735","display_name":"Universit\u00e0 Cattolica del Sacro Cuore","ror":"https://ror.org/03h7r5v07","country_code":"IT","type":"education","lineage":["https://openalex.org/I103320735"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Maria Grimaldi","raw_affiliation_strings":["Catholic University of Sacred Heart"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Catholic University of Sacred Heart","institution_ids":["https://openalex.org/I103320735"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113751815","display_name":"Nicola Mozzillo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nicola Mozzillo","raw_affiliation_strings":["O.U. Melanoma and Sarcoma Surgery Istituto Nazionale Tumori di Napoli Fondazione \u201cG. Pascale\u201d"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"O.U. Melanoma and Sarcoma Surgery Istituto Nazionale Tumori di Napoli Fondazione \u201cG. Pascale\u201d","institution_ids":["https://openalex.org/I4210141868"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029398339","display_name":"Paolo A. Ascierto","orcid":"https://orcid.org/0000-0002-8322-475X","observed_orcids":["https://orcid.org/0000-0002-8322-475X"]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Paolo A Ascierto","raw_affiliation_strings":["Istituto Nazionale Tumori Fondazione G. Pascale"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Nazionale Tumori Fondazione G. Pascale","institution_ids":["https://openalex.org/I4210141868"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5029398339"],"corresponding_institution_ids":["https://openalex.org/I4210141868"],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":11,"reviewed_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"3","issue":"Suppl 2","first_page":"P186","last_page":"P186"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.996999979019165},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.9850000143051147},{"id":"https://openalex.org/keywords/advanced-melanoma","display_name":"advanced melanoma","score":0.8330000042915344},{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.8650000095367432},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.7369999885559082},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.6549999713897705},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.6700000166893005}],"concepts":[{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.9850600957870483},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.930230975151062},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8187640905380249},{"id":"https://openalex.org/C2994587330","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Metastatic melanoma","level":3,"score":0.6847819685935974},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.639796257019043},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.6173326373100281},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.598463237285614},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5423246026039124},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4797550439834595},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4726504385471344},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.460151731967926},{"id":"https://openalex.org/C117220453","wikidata":"https://www.wikidata.org/wiki/Q5172842","display_name":"Correlation","level":2,"score":0.4142954349517822},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3495108485221863},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.173201322555542},{"id":"https://openalex.org/C2524010","wikidata":"https://www.wikidata.org/wiki/Q8087","display_name":"Geometry","level":1,"score":0.0},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1186/2051-1426-3-s2-p186","doi":"https://doi.org/10.1186/2051-1426-3-s2-p186","is_oa":true,"landing_page_url":"https://doi.org/10.1186/2051-1426-3-s2-p186","pdf_url":"https://jitc.biomedcentral.com/track/pdf/10.1186/2051-1426-3-S2-P186","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for ImmunoTherapy of Cancer","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4649387","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4649387/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Immunother Cancer","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1186/2051-1426-3-s2-p186","doi":"https://doi.org/10.1186/2051-1426-3-s2-p186","is_oa":true,"landing_page_url":"https://doi.org/10.1186/2051-1426-3-s2-p186","pdf_url":"https://jitc.biomedcentral.com/track/pdf/10.1186/2051-1426-3-S2-P186","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for ImmunoTherapy of Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2226252183.pdf","grobid_xml":"https://content.openalex.org/works/W2226252183.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2227931589","https://openalex.org/W2210257471","https://openalex.org/W3085614694","https://openalex.org/W3005150264","https://openalex.org/W4231371687","https://openalex.org/W2338494814","https://openalex.org/W2408358459","https://openalex.org/W3031098542","https://openalex.org/W7021125281","https://openalex.org/W2890208257"],"abstract_inverted_index":{"Meeting":[0],"abstracts":[1],"Immunomodulation":[2],"with":[3,27],"pembrolizumab":[4],"(anti-PD-1)":[5],"has":[6],"been":[7],"shown":[8],"to":[9],"reach":[10],"significant":[11],"objective":[12],"response":[13],"(RR)":[14],"and":[15,24,35],"extend":[16],"overall":[17],"survival":[18],"(OS)":[19],"both":[20],"in":[21],"ipilimumab":[22],"pre-treated":[23],"naive":[25],"patients":[26],"metastatic":[28],"melanoma.":[29],"While":[30],"this":[31],"immunotherapy":[32],"gives":[33],"OS":[34],"OR":[36],"benefits,":[37],"it":[38],"can":[39],"also":[40]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2226252183","counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
